Loading...
01/11 03:44
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial performance, with significant revenue and gross profit growth, improved margins, and reduced losses. The Q&A section reveals optimism about profitability in Q4 and sustained growth through R&D and marketing optimization. Despite competition, the company's strategy to focus on high-end brands and innovation is promising. The lack of detailed guidance on expenses is a minor concern, but overall, the positive financial results and optimistic outlook suggest a positive stock price movement.
Total Net Revenues RMB 998.4 million, a 47.5% increase year-over-year. The increase was primarily due to an 83.2% year-over-year increase in net revenues from skincare brands and a 25.2% year-over-year increase in revenue from color cosmetics brands.
Gross Profit RMB 780.5 million, a 51.9% increase year-over-year. The increase was primarily driven by an increase in sales of higher gross margin products.
Gross Margin 78.2%, up from 75.9% in the prior year period. The increase was primarily driven by an increase in sales of higher gross margin products.
Total Operating Expenses RMB 864.1 million, a 31.9% increase year-over-year. As a percentage of total net revenues, it decreased to 86.5% from 96.8% in the prior year period.
Fulfillment Expenses RMB 61.8 million, up from RMB 50.4 million in the prior year period. As a percentage of total net revenues, it decreased to 6.2% from 7.4%, primarily driven by fulfillment cost optimization and the leveraging effect of higher total net revenues.
Selling and Marketing Expenses RMB 682.3 million, up from RMB 494.4 million in the prior year period. As a percentage of total net revenues, it decreased to 68.3% from 73%, driven by a higher skincare mix and more disciplined spending across channels.
General and Administrative Expenses RMB 80.2 million, down from RMB 85 million in the prior year period. As a percentage of total net revenues, it decreased to 8% from 12.6%, primarily driven by lower share-based compensation expenses and the leveraging effect of higher total net revenues.
Research and Development Expenses RMB 39.8 million, up from RMB 25.3 million in the prior year period. As a percentage of total net revenues, it increased to 4% from 3.7%, primarily driven by higher payroll expenses due to an increase in R&D headcount.
Loss from Operations RMB 83.6 million, down from RMB 141.3 million in the prior year period. Operating loss margin improved to 8.4% from 20.9%.
Net Loss RMB 70.4 million, down from RMB 121.1 million in the prior year period. Net loss margin improved to 7% from 17.9%.
Non-GAAP Net Loss RMB 51.5 million, down from RMB 76.6 million in the prior year period. Non-GAAP net loss margin improved to 5.2% from 11.3%.
Cash, Restricted Cash, and Short-term Investments RMB 1.16 billion as of September 30, 2025, down from RMB 1.36 billion as of December 31, 2024.
Net Cash Used in Operating Activities RMB 126.8 million, down from RMB 175.9 million in the prior year period. The decrease was primarily due to working capital movements, including inventory positioning and receivables timing ahead of Double 11.
Skincare brands growth: Skincare brands grew by 83.2% year-over-year, reaching 49.2% of total revenue. Galénic's hero serum series performed well, with the newly launched VB serum becoming a best-seller. DR. WU launched its first anti-aging product in the U.K., gaining traction with innovative formulations. Perfect Diary focused on hero product quality, with its space makeup category exceeding 40% of total sales.
Market expansion: DR. WU entered the U.K. market with its first anti-aging product, leveraging clinical expertise. Perfect Diary achieved #1 ranking among makeup brands on WeChat video channel, reflecting strengthened competitiveness.
Revenue growth: Total net revenues increased by 47.5% year-over-year to RMB 998.4 million, driven by skincare and color cosmetics brands.
Profitability improvement: Net loss margin improved from 17.9% to 7% year-over-year due to gross margin optimization and disciplined resource allocation.
R&D and innovation: Participated in IFCC Congress for the fourth consecutive year, with 11 papers shortlisted. Focused on advancing scientific research to support hero product development and long-term competitiveness.
Market Conditions: The beauty market in China is showing signs of recovery, but there is no guarantee that this trend will continue, which could impact future revenue growth.
Profitability Challenges: Despite narrowing net losses, the company is still operating at a loss, with a net loss margin of 7% for the quarter. Achieving profitability remains a challenge.
High Operating Expenses: Total operating expenses remain high at 86.5% of total net revenues, which could hinder profitability if not managed effectively.
Seasonal Marketing Investments: The company has made significant upfront investments for the Double 11 shopping season, which elevate short-term selling and marketing expenses and may not yield the expected long-term benefits.
Cash Flow Concerns: Net cash used in operating activities was RMB 126.8 million for the quarter, indicating ongoing cash flow challenges.
Regulatory Risks: Forward-looking statements are subject to risks and uncertainties, some of which are beyond the company's control, potentially impacting future performance.
Supply Chain and Inventory Management: Working capital movements, including inventory positioning ahead of Double 11, could pose risks if inventory efficiency is not optimized.
Profitability Progression: The company aims to continue progressing toward profitability in a disciplined and sustainable manner. This will be driven by a higher income mix, ongoing gross margin optimization, and greater marketing efficiency.
Investment in Innovation: Yatsen plans to continue investing in innovation and hero products while maintaining a balance between growth and profitability.
Revenue Projections for Q4 2025: The company expects total net revenues for the fourth quarter of 2025 to be between RMB 1.32 billion and RMB 1.49 billion, representing a year-over-year increase of approximately 15% to 30%.
Operational Improvements: Yatsen anticipates improved operating cash flow in the fourth quarter as investments convert into revenue and inventory efficiency and marketing ROI are optimized.
Brand and Product Development: The company will prioritize investments that strengthen core brands and innovation capabilities, aiming for long-term shareholder value creation.
The selected topic was not discussed during the call.
The earnings call highlights strong financial performance, with significant revenue and gross profit growth, improved margins, and reduced losses. The Q&A section reveals optimism about profitability in Q4 and sustained growth through R&D and marketing optimization. Despite competition, the company's strategy to focus on high-end brands and innovation is promising. The lack of detailed guidance on expenses is a minor concern, but overall, the positive financial results and optimistic outlook suggest a positive stock price movement.
The earnings call reveals strong financial performance with increased gross margin, reduced operating losses, and a shift to non-GAAP net income. The strategic focus on high-margin skincare and R&D investments, alongside a share repurchase program, indicates confidence in future growth. Positive Q3 guidance for skincare and improved profitability strategies further bolster the outlook. Despite increased competition, the company's robust R&D capabilities and strategic initiatives suggest a positive trajectory. The Q&A section supports this with no significant concerns raised by analysts, reinforcing the positive sentiment.
The earnings call presents a mixed picture. Financial performance shows improvement, with increased net revenues, gross profit, and reduced losses, yet color cosmetics face a decline, reflecting market challenges. Regulatory and supply chain issues persist, and management's responses lacked clarity, especially regarding product promotion and sales forecasts. The share repurchase program is a positive, but the absence of concrete guidance tempers optimism. Overall, the sentiment is neutral, as the positives are balanced by ongoing challenges and uncertainties.
The earnings call reveals declining revenues and significant market challenges, particularly in the beauty sector. Despite improvements in gross margin and reduced net loss, the absence of a share repurchase program and liquidity concerns indicate financial instability. The Q&A section highlights vague responses, adding uncertainty. While there is optimistic guidance for Q4 2024, the negative sentiment from declining industry trends and strategic risks outweighs potential positives, leading to a likely negative stock price reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
